Health
3 Reasons to Buy Moderna Now – Motley Fool
The shares have surged in the triple digits since the start of the year. And additional gains may be on the horizon.
Moderna(NASDAQ:MRNA) has taken center stage in the race to develop a coronavirus vaccine. In March, the clinical-stage biotech company became the first to bring a vaccine into human trials. Since then, management has reported encouraging trial data that allowed it to move on to phase 3 studies — a final and crucial step before regulatory approval. Since the start of the year, the shares have surged by 297%.
Some investors may wonder if, considering the share gains, there is any steam left. Of …
-
General16 hours agoSex work influencers call out lack of transparency as young girls targeted by viral social media content
-
Noosa News12 hours agoGaming policy on council’s agenda
-
Business14 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General10 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism